← Eichor
Condition: Anticoagulant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Anticoagulant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05638867Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
NA · 1 location(s) · Chinese University of Hong Kong · NCT06241677Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06954610Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
Phase 3 · 28 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT05627375Anticoagulation After GI Bleeding Pilot Study and Registry
NA · 2 location(s) · Ottawa Hospital Research Institute · NCT05290857Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )
NA · 20 location(s) · University Hospital, Brest · NCT06731244Caudal Analgesia & Anticoagulated Patient
Phase N/A · 1 location(s) · Salem Anaesthesia Pain Clinic · NCT05946850Management of Gastrointestinal Bleeding Under Direct Oral Anticoagulants
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07333144Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (
Phase N/A · 1 location(s) · Nedim Tojaga · NCT06949319Vitamin K for Perioperative Warfarin Management
Phase 4 · 1 location(s) · University of Michigan · NCT07515664External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · 16 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chroni
Phase N/A · 1 location(s) · University Hospital, Clermont-Ferrand · NCT04701749Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis
Phase 1 · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04874428IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Phase 2 · 3 location(s) · David Ware Branch · NCT03152058Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
NA · 4 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06386107Phase I Study of MT1011 Injection in Healthy Subjects
Phase 1 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT07024160Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation
Phase N/A · 1 location(s) · University Hospital, Motol · NCT06868823Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] - "MC-MORPH
Phase N/A · 1 location(s) · University Hospital, Brest · NCT07328152Intravenous Thrombolysis and NOAC
Phase 3 · 2 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06749834Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT07183605Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronym
EARLY_Phase 1 · 1 location(s) · Aplagon Oy · NCT06204237Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrill
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT06187311Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04660747Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Phase 4 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06486792Timing of Resumption of Direct Oral Anticoagulants Following Polypectomy
NA · 1 location(s) · The University of Hong Kong · NCT06482333PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
Phase 3 · 12 location(s) · Sunnybrook Health Sciences Centre · NCT03559114Selective CT for Anticoagulated Head Injured Patients
Phase N/A · 7 location(s) · Dr. Kerstin de Wit · NCT05364749Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support
Phase 4 · 1 location(s) · Medical University of Vienna · NCT06442267Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Phase 2 · 5 location(s) · Stanford University · NCT06080074
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.